These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 16145000

  • 1. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]

  • 2. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 3. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
    Eto H, Miyata M, Shirasawa T, Akasaki Y, Hamada N, Nagaki A, Orihara K, Biro S, Tei C.
    Hypertens Res; 2008 Aug 25; 31(8):1631-42. PubMed ID: 18971539
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of the AT2 receptor reduced atherogenesis in ApoE(-/-)/AT1A(-/-) double knock out mice.
    Tiyerili V, Mueller CF, Becher UM, Czech T, van Eickels M, Daiber A, Nickenig G, Wassmann S.
    J Mol Cell Cardiol; 2012 Mar 25; 52(3):630-7. PubMed ID: 22230040
    [Abstract] [Full Text] [Related]

  • 5. [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
    Liu HW, Cheng B, Wu HJ, Gu YF, Chen X, Chen ZG, Liu WZ.
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Jan 25; 26(1):57-60. PubMed ID: 20432929
    [Abstract] [Full Text] [Related]

  • 6. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T, Iwai M, Li Z, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M.
    Hypertens Res; 2006 Jun 25; 29(6):457-66. PubMed ID: 16940709
    [Abstract] [Full Text] [Related]

  • 7. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
    Iwai M, Liu HW, Chen R, Ide A, Okamoto S, Hata R, Sakanaka M, Shiuchi T, Horiuchi M.
    Circulation; 2004 Aug 17; 110(7):843-8. PubMed ID: 15289370
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells.
    Kagawa T, Takao T, Horino T, Matsumoto R, Inoue K, Morita T, Hashimoto K.
    Nephrology (Carlton); 2008 Jun 17; 13(4):309-15. PubMed ID: 18331441
    [Abstract] [Full Text] [Related]

  • 9. Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.
    Suzuki J, Iwai M, Mogi M, Oshita A, Yoshii T, Higaki J, Horiuchi M.
    Arterioscler Thromb Vasc Biol; 2006 Apr 17; 26(4):917-21. PubMed ID: 16424347
    [Abstract] [Full Text] [Related]

  • 10. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M.
    Cardiovasc Res; 2007 Dec 01; 76(3):506-16. PubMed ID: 17706954
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
    Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L.
    Cardiovasc Res; 2008 Jun 01; 78(3):581-9. PubMed ID: 18281370
    [Abstract] [Full Text] [Related]

  • 12. Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
    Takata H, Yamada H, Kawahito H, Kishida S, Irie D, Kato T, Wakana N, Miyagawa S, Fukui K, Matsubara H.
    J Renin Angiotensin Aldosterone Syst; 2015 Jun 01; 16(2):311-20. PubMed ID: 23736171
    [Abstract] [Full Text] [Related]

  • 13. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec 01; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress.
    Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M.
    Hypertension; 2005 Apr 01; 45(4):545-51. PubMed ID: 15723967
    [Abstract] [Full Text] [Related]

  • 15. c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.
    Touyz RM, Yao G, Schiffrin EL.
    Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):981-7. PubMed ID: 12663375
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
    Liu HW, Cheng B, Yu WL, Sun RX, Zeng D, Wang J, Liao YX, Fu XB.
    Life Sci; 2006 Jun 27; 79(5):475-83. PubMed ID: 16522324
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
    Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, Sowers JR.
    Am J Physiol Endocrinol Metab; 2007 Jul 27; 293(1):E355-63. PubMed ID: 17440033
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation.
    Fukuda D, Enomoto S, Nagai R, Sata M.
    Biomed Pharmacother; 2009 Dec 27; 63(10):754-61. PubMed ID: 19304450
    [Abstract] [Full Text] [Related]

  • 19. AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice.
    Iwai M, Tomono Y, Inaba S, Kanno H, Senba I, Mogi M, Horiuchi M.
    Am J Hypertens; 2009 Jul 27; 22(7):784-91. PubMed ID: 19444223
    [Abstract] [Full Text] [Related]

  • 20. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL, Li YH, Shi GY, Tang SH, Jiang SJ, Huang CW, Liu PY, Hong JS, Wu HL.
    Cardiovasc Res; 2009 Apr 01; 82(1):161-9. PubMed ID: 19189960
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.